Cosmos Health Inc. · NASDAQ:COSM

Cosmos Health — Investor Presentation (October 2022)

18 slides from Cosmos Health's investor presentation, October 2022

  1. Slide 1: Cosmos Holdings Inc. Company Presentation October 2022

    COSMOS HOLDINGS INC. (NASDAQ: COSM) OCTOBER 2022 COMPANY PRESENTATION

  2. Slide 2: Disclaimer

    DISCLAIMER This presentation is not an offer to sell securities, nor is it a solicitation of an offer to buy securities in any locality, state, country or other jurisdiction where such distribution, publication, availability or use would be contrary to law or regulation, or which would require any reg

  3. Slide 3: Cosmos Health at a Glance

    2009 Cosmos Health was founded Global HQ in Chicago, IL, US and offices in Thessaloniki, Greece, Athens, Greece, Harlow, UK Cosmos Health at a Glance Uplisting February 28, 2022 (Nasdaq: COSM) Our mission is to improve people’s lives. 95 Employees as of December 31, 2021 $56.2M FY’21 revenue 3

  4. Slide 4: Cosmos Health: An International Healthcare Group

    COSMOS HEALTH AN INTERNATIONAL HEALTHCARE GROUP Who we are What we do How we do it • We are Cosmos Health, an • We develop and distribute our own • We prioritize our customers’ needs, international healthcare group. proprietary line of nutraceuticals as focusing on the latest scientific well as a br

  5. Slide 5: Our Strategy

    OUR STRATEGY Our focus is high We use our extended margin nutraceuticals network to gain and R&D efforts to access to new develop IP products markets and business segments. Diversification allows us to exploit new opportunities and synergies while minimizing risk. 5

  6. Slide 6: The Team

    THE TEAM Greg Siokas Pavlos Ignatiades George Terzis Chief Executive Officer Chief Operating Officer Chief Financial Officer Greg Siokas has over 20 years of experience in the Pavlos Ignatiades has been a senior portfolio manager George Terzis oversees all Cosmos’ financial pharma industry. He has w

  7. Slide 7: Cosmos Group Overview

    COSMOS GROUP OVERVIEW • Corporate Office in the Chicago • Office area of 850m2, fully • State of the art GDP warehouse, • Warehouse area of 400m2, Board of Trade Building,141 West equipped & air-conditioned of total surface area of 2,900m2, licensed under GDP with Jackson Blvd, Chicago, Illinois. •

  8. Slide 8: Market Analysis

    MARKET ANALYSIS Nutraceuticals Pharmaceuticals Healthcare Distribution ❖ Global Nutraceuticals Market was valued at ❖ The Global Pharmaceuticals Market is expected to ❖ Global Healthcare Distribution Market was valued $455bn in 2021 and is expected to reach grow from $1,455bn in 2021 to $1,587 in 20

  9. Slide 9: Our Business Model

    OUR BUSINESS MODEL Nutraceuticals Pharmaceuticals Healthcare Distribution • “Sky Premium Life” and “Mediterranation” • Exclusivity on medicine licenses of fast-moving • Direct distribution and sales of pharmaceuticals, high-end brands of premium nutraceuticals product codes medical devices, generics

  10. Slide 10: Our Sale Channels / Our Partners

    OUR SALE CHANNELS OUR PARTNERS 10

  11. Slide 11: Development of New Products & Product Lines

    DEVELOPMENT OF NEW PRODUCTS & PRODUCT LINES Eleonas Chios Mastic Mediterranation • Sage, mint, basil, sideritis extracts in • Chios mastic organic extra virgin olive oil • Inulin • Vitamins E, K2, D3 • Digestive system support • Cardiovascular system support and antioxidant action Olympus Mons Chios

  12. Slide 12: Gut Microbiome-Based R&D

    GUT MICROBIOME-BASED R&D Food Supplements Medical Devices FSMPs Pharmaceuticals Medical Fields Collaborations ❖ Bone remodeling ❖ Weight management ❖ IBD/ Chron Disease ❖ Metabolic syndrome 12

  13. Slide 13: Key Milestones

    KEY MILESTONES 05 Uplisting to Nasdaq Stock Exchange Q1 2022 07 Launch of nutraceutical brand 01 Acquisition of 03 Launch of Mediterranation Decahedron Ltd in UK nutraceutical brand Q2 2022 Q2 2017 Sky Premium Life Q4 2019 2017 2018 2019 2020 2022 08 Change of name from 06 Strategic Cosmos partnersh

  14. Slide 14: Key – Recent 2022 Events

    KEY – RECENT 2022 EVENTS Date Description Feb 28, 2022 Cosmos Health announced Nasdaq Uplisting and concurrent private placement. Launch of: ▪ Sky Premium Life Prostatium supplement for prostate health and Brainlit supplement for brain health. Mar 28-Apr 12, 2022 ▪ New premium nutritional supplement

  15. Slide 15: Key Figures

    KEY FIGURES Financial Highlights H1 2022 Trading data (10/04/2022) Capital Structure (06/30/2022) Adjusted EBITDA Stock price # of $ % of Fully Security WAEP Shares Value Diluted $1.1 million $0.19 Common Shares Outstanding 23,998,872 $8,879,583 47.75% $26.3 million $5.1 million Total revenue Market

  16. Slide 16: Market Data - Comparable Companies

    MARKET DATA - COMPARABLE COMPANIES Operating Statistics Capitalization Financial Metrics Company Market Enterprise Revenue EBITDA Ticker Market Cap / Revenue Market Cap / EBITDA Name Cap Value (TTM) (TTM) RVLP RVL Pharmaceuticals plc $208.22 $224.08 $34.95 N/M 5.96x N/M CDXC ChromaDex Corporation $8

  17. Slide 17: Why to Invest in Cosmos Health?

    WHY TO INVEST IN COSMOS HEALTH ? ❖ Significantly Undervalued Company ❖ Proven Revenue Growth Track record ❖ Well-positioned in the Marketplace with Established Sales Networks ❖ Innovative Nutraceutical Products based on extended R&D efforts ❖ Unique A to Z Business Model that distinguish us from com

  18. Slide 18: Thank You

    THANK YOU 141 West Jackson Blvd., Suite 4236 Chicago, IL 60604 [email protected] (US) +1 312 536 3102

Cosmos Holdings Inc. (Cosmos Health) — Investor Presentation (October 2022) on 6ix